Status:
COMPLETED
Evaluating Novel Approaches for Estimating Awake and Sleep Blood Pressure
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Blood Pressure
Eligibility:
All Genders
19-87 years
Phase:
NA
Brief Summary
The purpose of the proposed study is to test whether measuring unattended blood pressure using an automated blood pressure monitor in a clinic setting without staff being present can reduce the need f...
Detailed Description
For many people, blood pressure levels differ when measured in a doctor's office versus during normal daily activities. Ambulatory blood pressure monitoring, also called ABPM, involves wearing a blood...
Eligibility Criteria
Inclusion
- Mean screening systolic blood pressure of 110 to \< 160 mm Hg at most recent visit
- Mean screening diastolic blood pressure of 70 to \<100 mm Hg at most recent visit
Exclusion
- Currently taking antihypertensive medications
- Known to be currently pregnant
- History of sleep apnea
- History of heart attack, stroke, or any cardiovascular disease
- History of arrhythmia (e.g. - atrial fibrillation or ventricular tachycardia)
- Completed ambulatory blood pressure monitoring in the past year
- Second shift, overnight, or jobs that will not allow ambulatory blood pressure device to measure every 30 minutes for 24 hours.
Key Trial Info
Start Date :
July 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2022
Estimated Enrollment :
654 Patients enrolled
Trial Details
Trial ID
NCT04307004
Start Date
July 15 2019
End Date
December 13 2022
Last Update
December 13 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham Hypertension Research Clinic
Birmingham, Alabama, United States, 35205
2
Columbia University Medical Center - Hypertension Center
New York, New York, United States, 10032